These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 6860615)
81. Direct delivery of anticancer agents: experimental treatment of intraocular malignancy. Liu HS; Refojo MF; Perry HD; Albert DM Invest Ophthalmol Vis Sci; 1978 Oct; 17(10):993-1004. PubMed ID: 700954 [TBL] [Abstract][Full Text] [Related]
82. Histopathologic changes following carmustine treatment of uveal Greene melanoma in rabbits. Ni C; Liu LH Graefes Arch Clin Exp Ophthalmol; 1983; 220(3):103-9. PubMed ID: 6852549 [TBL] [Abstract][Full Text] [Related]
83. Experimental combined systemic and local chemotherapy for intraocular malignancy. Liu HS; Refojo MF; Albert DM Arch Ophthalmol; 1980 May; 98(5):905-8. PubMed ID: 7378013 [TBL] [Abstract][Full Text] [Related]
84. Topical administration of the antineoplastic carmustine: tolerance of normal rabbit eyes. Henriquez AS; Liu LH; Refojo MF Curr Eye Res; 1981; 1(3):183-7. PubMed ID: 7297103 [TBL] [Abstract][Full Text] [Related]
85. Tolerance of normal rabbit eyes to the antineoplastic carmustine. Liu HS; Perry HD; Refojo MF Ophthalmologica; 1980; 181(1):41-6. PubMed ID: 7207972 [TBL] [Abstract][Full Text] [Related]
86. Pharmacokinetics of the antineoplastic agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in the aqueous and vitreous of rabbit. Ueno N; Refojo MF; Liu LH Invest Ophthalmol Vis Sci; 1982 Aug; 23(2):199-208. PubMed ID: 7096015 [TBL] [Abstract][Full Text] [Related]
87. Effectiveness of antitumor agents administered subcutaneously to L1210 leukemic mice in silicone rubber devices. Neil GL; Scheidt LG; Kuentzel SL; Moxley TE Chemotherapy; 1973; 18(1):27-40. PubMed ID: 4681847 [No Abstract] [Full Text] [Related]
88. Continuous cancer chemotherapy: nitrosourea diffusion through implanted silicone rubber capsules. Schmidt V; Zapol W; Prensky W; Wonders T; Wodinsky I; Kitz R Trans Am Soc Artif Intern Organs; 1972; 18(0):45-53. PubMed ID: 4679901 [No Abstract] [Full Text] [Related]
89. Release of a nitrosourea derivative from refillable silicone rubber implants for the treatment of intraocular malignancies. Refojo MF; Liu HS; Leong FL; Sidebottom D J Bioeng; 1978; 2(5):437-45. PubMed ID: 744769 [No Abstract] [Full Text] [Related]
90. Sustained release of BCNU for the treatment of intraocular malignancies in animal models. Liu HS; Refojo MF; Perry HD; Albert DM Invest Ophthalmol Vis Sci; 1979 Oct; 18(10):1061-7. PubMed ID: 478776 [TBL] [Abstract][Full Text] [Related]
91. Sustained release of carmustine (BCNU) for treatment of experimental intraocular malignancy. Liu LH; Refojo MF; Ni C; Ueno N; Albert DM Br J Ophthalmol; 1983 Jul; 67(7):479-84. PubMed ID: 6860615 [TBL] [Abstract][Full Text] [Related]
92. The role of BCNU polymer wafers (Gliadel) in the treatment of malignant glioma. Nagpal S Neurosurg Clin N Am; 2012 Apr; 23(2):289-95, ix. PubMed ID: 22440872 [TBL] [Abstract][Full Text] [Related]
93. Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies. Lin SH; Kleinberg LR Expert Rev Anticancer Ther; 2008 Mar; 8(3):343-59. PubMed ID: 18366283 [TBL] [Abstract][Full Text] [Related]
94. Nitrosoureas: a review of experimental antitumor activity. Schabel FM Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694 [TBL] [Abstract][Full Text] [Related]